These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21879389)

  • 21. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.
    Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A
    Microrna; 2020; 9(3):198-215. PubMed ID: 31686643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing human cancer: identification and uses of microRNAs.
    Nicolas FE; Lopez-Gomollon S; Lopez-Martinez AF; Dalmay T
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):94-105. PubMed ID: 21110826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs in cancer: biomarkers, functions and therapy.
    Hayes J; Peruzzi PP; Lawler S
    Trends Mol Med; 2014 Aug; 20(8):460-9. PubMed ID: 25027972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in human cancer: from research to therapy.
    Negrini M; Ferracin M; Sabbioni S; Croce CM
    J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA interference and cancer: endogenous pathways and therapeutic approaches.
    Dykxhoorn DM; Chowdhury D; Lieberman J
    Adv Exp Med Biol; 2008; 615():299-329. PubMed ID: 18437900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-coding RNAs as theranostics in human cancers.
    Redis RS; Berindan-Neagoe I; Pop VI; Calin GA
    J Cell Biochem; 2012 May; 113(5):1451-9. PubMed ID: 22213511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
    Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
    Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-21: a novel therapeutic target in human cancer.
    Pan X; Wang ZX; Wang R
    Cancer Biol Ther; 2010 Dec; 10(12):1224-32. PubMed ID: 21139417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
    Spizzo R; Rushworth D; Guerrero M; Calin GA
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating cancer with microRNA replacement therapy: A literature review.
    Hosseinahli N; Aghapour M; Duijf PHG; Baradaran B
    J Cell Physiol; 2018 Aug; 233(8):5574-5588. PubMed ID: 29521426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-7: a tumor suppressor miRNA with therapeutic potential.
    Kalinowski FC; Brown RA; Ganda C; Giles KM; Epis MR; Horsham J; Leedman PJ
    Int J Biochem Cell Biol; 2014 Sep; 54():312-7. PubMed ID: 24907395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
    Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of microRNA-26a in human cancer progression and clinical application.
    Chen J; Zhang K; Xu Y; Gao Y; Li C; Wang R; Chen L
    Tumour Biol; 2016 Jun; 37(6):7095-108. PubMed ID: 27039398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs in brain metastases: big things come in small packages.
    McDermott R; Gabikian P; Sarvaiya P; Ulasov I; Lesniak MS
    J Mol Med (Berl); 2013 Jan; 91(1):5-13. PubMed ID: 23138927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.